Skip to main content
. 2013 Jul 21;19(27):4356–4362. doi: 10.3748/wjg.v19.i27.4356

Table 4.

Characteristic of mutation analysis in two groups of patients with Wilson’s disease: with and without side effects during zinc sulphate therapy

Mutation analysis No. of patients during zinc sulphate therapy
Without side effects With side effects
Homozygous for p.H1069Q mutation 16 3
Compound heterozygous for p.H1069Q mutation 8 5
Carrier for p.H1069Q mutation 4 1
Carrier for a mutation other than p.H1069Q 0 5
Mutation other than p.H1069Q on two alleles 2 2
Lack of data 2 5